help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liang, F.
Right arrow Articles by Gardner, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liang, F.
Right arrow Articles by Gardner, D. G.
Endocrinology Vol. 140, No. 4 1695-1701
Copyright © 1999 by The Endocrine Society


ARTICLES

Sp1 Dependence of Natriuretic Peptide Receptor A Gene Transcription in Rat Aortic Smooth Muscle Cells1

Faquan Liang, Fred Schaufele and David G. Gardner

Metabolic Research Unit and Department of Medicine, University of California, San Francisco, California 94143

Address all correspondence and requests for reprints to: Dr. David G. Gardner, Box 0540, Metabolic Research Unit, University of California, San Francisco, California 94143. E-mail: gardner{at}itsa.ucsf.edu

The atrial natriuretic peptide receptor (NPR-A) Is expressed in smooth muscle cells of the vasculature, where it is thought to signal the vasodilatory properties of the peptide. Despite its important role as a regulator of cardiovascular homeostasis, relatively little is known of the genomic factors governing expression of this gene. We show here that NPR-A promoter activity is reduced by 50–75% when any of three GC-rich sites are mutated. Simultaneous mutation of all three leads to a >90% reduction in NPR-A promoter activity. Transfection of wild-type, but not mutant, decoy oliogonucleotides encoding any one of the sites reduces NPR-A activity, presumably reflecting competition for a common transcription factor. Gel shift analyses show that each of the wild-type, but not the mutant, sites interferes with the formation of selected DNA-protein complexes on the other sites. These complexes share similar electrophoretic mobility. Immunoperturbation studies show that one of these shared complexes contains Sp1, whereas two others contain Sp3. Overexpression of either Sp1 or Sp3 in a cell type containing very low levels of these transcription factors (i.e. Drosophila Schneider cells) leads to induction of the wild-type, but not the mutant, NPR-A promoter. The data suggest that the Sp1 family of transcription factors plays a central role in NPR-A gene transcription. The association of Sp1 family members with transcriptional regulation of a number of genes involved in hemodynamic control will be discussed.




This article has been cited by other articles:


Home page
HypertensionHome page
D. G. Gardner, S. Chen, D. J. Glenn, and C. L. Grigsby
Molecular Biology of the Natriuretic Peptide System: Implications for Physiology and Hypertension
Hypertension, March 1, 2007; 49(3): 419 - 426.
[Full Text] [PDF]


Home page
HypertensionHome page
D. Rahmutula, J. Cui, S. Chen, and D. G. Gardner
Transcriptional Regulation of Type B Human Natriuretic Peptide Receptor Gene Promoter: Dependence on Sp1
Hypertension, September 1, 2004; 44(3): 283 - 288.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Borgatti, I. Lampronti, A. Romanelli, C. Pedone, M. Saviano, N. Bianchi, C. Mischiati, and R. Gambari
Transcription Factor Decoy Molecules Based on a Peptide Nucleic Acid (PNA)-DNA Chimera Mimicking Sp1 Binding Sites
J. Biol. Chem., February 21, 2003; 278(9): 7500 - 7509.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Nawrocki, C. E. Goldring, R. M. Kostadinova, F. J. Frey, and B. M. Frey
In Vivo Footprinting of the Human 11beta -Hydroxysteroid Dehydrogenase Type 2 Promoter. EVIDENCE FOR CELL-SPECIFIC REGULATION BY Sp1 AND Sp3
J. Biol. Chem., April 19, 2002; 277(17): 14647 - 14656.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. C Kone
Molecular biology of natriuretic peptides and nitric oxide synthases
Cardiovasc Res, August 15, 2001; 51(3): 429 - 441.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. A. Lucas, G. M. Pitari, S. Kazerounian, I. Ruiz-Stewart, J. Park, S. Schulz, K. P. Chepenik, and S. A. Waldman
Guanylyl Cyclases and Signaling by Cyclic GMP
Pharmacol. Rev., September 1, 2000; 52(3): 375 - 414.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Yu, G. Schwartzbauer, A. Kazlman, and R. K. Menon
Role of the Sp Family of Transcription Factors in the Ontogeny of Growth Hormone Receptor Gene Expression
J. Biol. Chem., November 26, 1999; 274(48): 34327 - 34336.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Liang, F. Schaufele, and D. G. Gardner
Functional Interaction of NF-Y and Sp1 Is Required for Type A Natriuretic Peptide Receptor Gene Transcription
J. Biol. Chem., January 5, 2001; 276(2): 1516 - 1522.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society